Literature DB >> 28137615

Regulation of miR-29b-1/a transcription and identification of target mRNAs in CHO-K1 cells.

Penn Muluhngwi1, Kirsten Richardson1, Joshua Napier1, Eric C Rouchka2, Justin L Mott3, Carolyn M Klinge4.   

Abstract

miR-29b and miR-29a transcript levels were reported to increase in exponentially growing CHO-K1 cells. Here, we examine the regulation of miR-29b-1/a in CHO-K1 cells. We observed that 4-hydroxytamoxifen (4-OHT) increased pri-miR-29b-1 and pri-miR-29a transcription in CHO-K1 cells by activating endogenous estrogen receptor α (ERα). DICER, an established, bona fide target of miR-29b-1/a, was shown to be regulated by 4-OHT in CHO-K1 cells. We showed that miR-29b-1 and miR-29a serve a repressive role in cell proliferation, migration, invasion, and colony formation in CHO-K1 cells. To identify other targets of miR-29b-1 and miR-29a, RNA sequencing was performed by transfecting cells with anti-miR-29a, which inhibits both miR-29a and miR-29b-1, pre-miR-29b-1, and/or pre-miR-29a. In silico network analysis in MetaCore™ identified common and unique putative gene targets of miR-29b-1 and miR-29a. Pathway analysis of identified putative miR-29 targets were related to cell adhesion, cytoskeletal remodeling, and development. Further inquiry revealed regulation of pathways mediating responses to growth factor stimulus and cell cycle regulation. Copyright Â
© 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  4-Hydroxytamoxifen; CHO-K1; DICER1; ERα; RNA seq; miRNAs

Mesh:

Substances:

Year:  2017        PMID: 28137615      PMCID: PMC5316361          DOI: 10.1016/j.mce.2017.01.044

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  56 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA.

Authors:  G Hutvágner; J McLachlan; A E Pasquinelli; E Bálint; T Tuschl; P D Zamore
Journal:  Science       Date:  2001-07-12       Impact factor: 47.728

3.  Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells.

Authors:  Tissa T Manavalan; Yun Teng; Savitri N Appana; Susmita Datta; Theodore S Kalbfleisch; Yong Li; Carolyn M Klinge
Journal:  Cancer Lett       Date:  2011-09-10       Impact factor: 8.679

4.  Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans.

Authors:  R F Ketting; S E Fischer; E Bernstein; T Sijen; G J Hannon; R H Plasterk
Journal:  Genes Dev       Date:  2001-10-15       Impact factor: 11.361

Review 5.  25 years of recombinant proteins from reactor-grown cells - where do we go from here?

Authors:  David L Hacker; Maria De Jesus; Florian M Wurm
Journal:  Biotechnol Adv       Date:  2009-05-20       Impact factor: 14.227

6.  Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing.

Authors:  A Grishok; A E Pasquinelli; D Conte; N Li; S Parrish; I Ha; D L Baillie; A Fire; G Ruvkun; C C Mello
Journal:  Cell       Date:  2001-07-13       Impact factor: 41.582

7.  MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer.

Authors:  Dawn R Cochrane; Diana M Cittelly; Erin N Howe; Nicole S Spoelstra; Erin L McKinsey; Kelly LaPara; Anthony Elias; Douglas Yee; Jennifer K Richer
Journal:  Horm Cancer       Date:  2010-12       Impact factor: 3.869

8.  Effects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7.

Authors:  A E Lykkesfeldt; J K Larsen; I J Christensen; P Briand
Journal:  Br J Cancer       Date:  1984-06       Impact factor: 7.640

9.  Expression of dicer and its related miRNAs in the progression of prostate cancer.

Authors:  Xiaojie Bian; Yijun Shen; Guiming Zhang; Chenyuan Gu; Ying Cai; Chaofu Wang; Yiping Zhu; Yao Zhu; Hailiang Zhang; Bo Dai; Dingwei Ye
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

10.  Comprehensive genome and epigenome characterization of CHO cells in response to evolutionary pressures and over time.

Authors:  Julia Feichtinger; Inmaculada Hernández; Christoph Fischer; Michael Hanscho; Norbert Auer; Matthias Hackl; Vaibhav Jadhav; Martina Baumann; Peter M Krempl; Christian Schmidl; Matthias Farlik; Michael Schuster; Angelika Merkel; Andreas Sommer; Simon Heath; Daniel Rico; Christoph Bock; Gerhard G Thallinger; Nicole Borth
Journal:  Biotechnol Bioeng       Date:  2016-04-29       Impact factor: 4.530

View more
  5 in total

Review 1.  Recent developments in miRNA based recombinant protein expression in CHO.

Authors:  Masoume Bazaz; Ahmad Adeli; Mohammad Azizi; Masoud Soleimani; Fereidoun Mahboudi; Noushin Davoudi
Journal:  Biotechnol Lett       Date:  2022-05-04       Impact factor: 2.461

Review 2.  Factors Affecting the Expression of Recombinant Protein and Improvement Strategies in Chinese Hamster Ovary Cells.

Authors:  Zheng-Mei Li; Zhen-Lin Fan; Xiao-Yin Wang; Tian-Yun Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-07-04

3.  Exploring the molecular content of CHO exosomes during bioprocessing.

Authors:  Christoph Keysberg; Oliver Hertel; Louise Schelletter; Tobias Busche; Chiara Sochart; Jörn Kalinowski; Raimund Hoffrogge; Kerstin Otte; Thomas Noll
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-03       Impact factor: 4.813

Review 4.  The Effect of microRNA on the Production of Recombinant Protein in CHO Cells and its Mechanism.

Authors:  Hui-Ning Liu; Wei-Hua Dong; Yan Lin; Zhao-Hui Zhang; Tian-Yun Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-03-21

5.  Variation in MicroRNA Expression Profile of Uterine Leiomyoma with Endometrial Cavity Distortion and Endometrial Cavity Non-Distortion.

Authors:  Yong Jin Kim; Yoon Young Kim; Jung Ho Shin; Hoon Kim; Seung-Yup Ku; Chang Suk Suh
Journal:  Int J Mol Sci       Date:  2018-08-25       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.